Report post

Is Atos (Atos) a good stock to buy?

ATOSSA THERAPEUTICS INC's number of analysts covering the stock is greater than practically none of all US stocks. ATOS has a lower variance in analysts' estimates than just about 100% of all US stocks. In the context of Healthcare stocks, ATOSSA THERAPEUTICS INC's average analyst price target is greater than 17.16% of them.

What is the target price for Atos SE shares?

The analyst consensus target price for shares in Atos SE is €41.93 . That is 29.25% above the last closing price of €32.44. Analysts covering Atos SE currently have a consensus Earnings Per Share (EPS) forecast of €3.56 for the next financial year. What is the trend in the Atos SE share price?

What is the market capitalisation of Atos SE shares?

As of the previous close price of €32.44, shares in Atos SE had a market capitalisation of €3.57bn. Where are Atos SE shares listed? What kind of share is Atos SE?

The World's Leading Crypto Trading Platform

Get my welcome gifts